Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:MOMENTUM50Healthcare
Clear all filters
Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026
neutral
LiveMint - Markets 142d ago

Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026

Shares to buy or sell: Chandan Taparia has recommended two stocks to buy today, 20 February 2026 - Oil and Natural Gas Corporation (ONGC) and RBL Bank shares - and has suggested selling Info Edge (India) stock futures.

BANKINDIACHANDANMOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUENAUKRIOILOILIETFONGCRBLBANKConsumer ServicesFinancial Services
Market Trading Guide: ONGC among 2 stocks to buy on Friday for up to 16% returns
neutral
ET Markets - Stocks 142d ago

Market Trading Guide: ONGC among 2 stocks to buy on Friday for up to 16% returns

Nifty ended sharply lower as US-Iran tensions sparked a broad sell-off, breaking its three-day gain streak. Stock picks include ONGC and Biocon, showing strong bullish momentum on short-term charts. Traders are advised to follow breakout levels with prudent stop-losses.

AONETMMQ50AONETOTALBIOCONGROWWMOM50LTGILTBEESMIDSMALLMOCAPITALMOM30IETFMOMENTUMMOMENTUM30MOMENTUM50MOMIDMTMMOMOMENTUMONGCPRUDENTSMALLCAPFinancial ServicesHealthcare
Buy Niva Bupa Health Insurance; target of Rs 100: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Niva Bupa Health Insurance; target of Rs 100: Motilal Oswal

Motilal Oswal recommended is bullish on Niva Bupa Health Insurance recommended buy rating on the stock with a target price of Rs 100 in its research report dated Jun 19, 2026.

MEDANTAMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUENIVABUPASTARHEALTHFinancial ServicesHealthcare
Sensex Today | Stock Market Live: GIFT Nifty indicates a firm start; Promoter to sell stake in Vedanta
positive
Moneycontrol NaNd ago

Sensex Today | Stock Market Live: GIFT Nifty indicates a firm start; Promoter to sell stake in Vedanta

Sensex Today | Stock Market LIVE Updates: The S&P 500 and the Nasdaq closed down on Monday, dragged by ​declines in the megacap technology stocks including Alphabet, while investors assessed developments in U.S.-Iran negotiations. The Dow closed higher, boosted by ‌the healthcare and industrial sectors. The Dow Jones Industrial Average rose 148.01 points, or 0.29%, to 51,712.71, the ​S&P 500 lost 27.79 points, or 0.37%, to 7,472.79 and the Nasdaq Composite lost 351.33 points, or 1.32%, to 26,166.60.

AONETMMQ50AONETOTALGROWWLOVOLGROWWMOM50HCGHCG-REHDFCGROWTHHEALTHADDHEALTHAXISHEALTHCAREHEALTHIETFHEALTHYMOCAPITALMOMENTUM50MONIFTY500MULTICAPVALUEVEDLFinancial ServicesHealthcare
Buy Five Star Business Finance; target of Rs 600: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Five Star Business Finance; target of Rs 600: Motilal Oswal

Motilal Oswal recommended is bullish on Five Star Business Finance recommended buy rating on the stock with a target price of Rs 600 in its research report dated Jun 22, 2026.

FIVESTARLTFMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESTARFinancial ServicesHealthcare
Buy Laurus Labs; target of Rs 1280: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Laurus Labs; target of Rs 1280: Motilal Oswal

Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1280 in its research report dated February 25, 2026.

LAURUSLABSMOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Neutral Blue Star; target of Rs 1920: Motilal Oswal
positive
Moneycontrol NaNd ago

Neutral Blue Star; target of Rs 1920: Motilal Oswal

Motilal Oswal recommended Neutral rating on Blue Star with a target price of Rs 1920 in its research report dated May 07, 2026.

BLUESTARCOMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESTARConsumer DurablesFinancial Services
Neutral ALKEM Laboratories; target of Rs 5525: Motilal Oswal
neutral
Moneycontrol NaNd ago

Neutral ALKEM Laboratories; target of Rs 5525: Motilal Oswal

Motilal Oswal recommended Neutral rating on ALKEM Laboratories with a target price of Rs 5525 in its research report dated February 14, 2026.

ALKEMMOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Neutral Eris Lifesciences; target of Rs 1520: Motilal Oswal
neutral
Moneycontrol NaNd ago

Neutral Eris Lifesciences; target of Rs 1520: Motilal Oswal

Motilal Oswal recommended Neutral rating on Eris Lifesciences with a target price of Rs 1520 in its research report dated February 14, 2026.

ERISMOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Neutral Lupin; target of Rs 2360: Motilal Oswal
neutral
Moneycontrol NaNd ago

Neutral Lupin; target of Rs 2360: Motilal Oswal

Motilal Oswal recommended Neutral rating on Lupin with a target price of Rs 2360 in its research report dated February 14, 2026.

LUPINMOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Neutral Torrent Pharma; target of Rs 4300: Motilal Oswal
neutral
Moneycontrol NaNd ago

Neutral Torrent Pharma; target of Rs 4300: Motilal Oswal

Motilal Oswal recommended Neutral rating on Torrent Pharma with a target price of Rs 4300 in its research report dated February 14, 2026.

MOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESPARCFinancial ServicesHealthcare
Buy Star Health; target of Rs 700: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Star Health; target of Rs 700: Motilal Oswal

Motilal Oswal is bullish on Star Health recommended buy rating on the stock with a target price of Rs 700 in its research report dated Jun 25, 2026.

MEDANTAMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESTARSTARHEALTHFinancial ServicesHealthcare